← Open Payments lookup

CHARLOTTE BUDZIK: Open Payments

NPI 1811975303 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,175 in 217 payments from 14 companies in 2025. Trend: 2023 $1,084 · 2024 $1,439 · 2025 $5,175

Food & beverage: $5,091Education: $84
CompanyPaymentsAmount
ABBVIE INC.52$1,345
Janssen Biotech, Inc.28$784
Madrigal Pharmaceuticals25$621
Salix Pharmaceuticals, a division of Bausch Health US, LLC26$544
PFIZER INC.20$466
Takeda Pharmaceuticals U.S.A., Inc.21$399
GENZYME CORPORATION7$269
Ardelyx, Inc.11$254
Phathom Pharmaceuticals, Inc.13$202
Organon LLC4$94

Products named: TREMFYA, REZDIFFRA, RINVOQ, XIFAXAN, SKYRIZI, XELJANZ, ENTYVIO, DUPIXENT.

Industry payments across PA — which companies pay providers there.